If you are wondering whether Arrowhead Pharmaceuticals’ current share price offers good value, this article will walk through what the numbers are saying about the stock.
The share price is at US$67.60, with returns of 2.6% over the last 7 days, a 2.0% decline over 30 days, a 0.3% decline year to date, a 243.0% gain over 1 year, a 105.0% gain over 3 years, and a 12.0% decline over 5 years.
Recent price moves sit against a backdrop of continuing interest in the company, with investors reacting to news around Arrowhead Pharmaceuticals’ pipeline progress and partnerships. This mix of attention and changing expectations helps explain some of the recent share price swings.
On Simply Wall St’s 6 point valuation check, Arrowhead…
